Coadministration of alpha-fetoprotein and an...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61K 38/16 (2006.01) A61K 38/21 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2673398

The present invention features methods for treating multiple sclerosis by administering an alpha-fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and one or more immunomodulatory agents to a patient in need thereof. Also disclosed are compositions and kits that contain an alpha-fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and one or more immunomodulatory agents.

La présente invention concerne des procédés pour traiter la sclérose en plaques par l'administration d'un polypeptide d'alpha-foetoprotéine (ou d'un fragment, dérivé ou analogue de celui-ci biologiquement actifs) et d'un ou plusieurs agents immunomodulateurs à un patient en ayant besoin. L'invention concerne également des compositions et des coffrets qui contiennent un polypeptide d'alpha-foetoprotéine (ou un fragment, dérivé ou analogue de celui-ci biologiquement actifs) et un ou plusieurs agents immunomodulateurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Coadministration of alpha-fetoprotein and an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coadministration of alpha-fetoprotein and an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coadministration of alpha-fetoprotein and an... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1909418

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.